Jonathon C. Arnold, Ph.D. University of Sydney, Australia 2009 Young Investigator Grant New research in mice reveals how THC, the main psychoactive compound in cannabis, can reduce the effectiveness of risperidone, an antipsychotic drug used widely to treat people with schizophrenia. Earlier studies have suggested that cannabis use can reduce the effectiveness of antipsychotic treatments and … Continue reading Study Suggests Cannabis Compound Can Make Schizophrenia Medication Less Effective
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia Jari Tiihonen M.D., Ph.D. Antti Tanskanen Phil.Lic. Heidi Taipale Ph.D. Published Online:6 Apr 2018https://doi.org/10.1176/ appi.ajp.2018.17091001 Abstract Objective: It is generally believed that after the first episode of schizophrenia, the risk of relapse decreases with time in patients who are stabilized. Many treatment guidelines recommend that after … Continue reading Long-term Antipsychotic Treatment is Associated with Increased Survival.
Antipsychotics saved my life. I am also one of the 500,000 people who got tardive dyskinesia (TD) from antipsychotics. My form of TD is extremely rare and shouldn’t prevent anybody from taking antipsychotics.
Tardive dyskinesia (TD) is a movement disorder that occurs in some people who take first-generation antipsychotics (such as haloperidol, chlorpromazine), and to a lesser degree second-generation antipsychotics (such as aripiprazole or paliperidone). TD results in repetitive, involuntary movements commonly of the face, lips and limbs.